ClinicalTrials.gov
public full text
Public Domain
Study of NM8074 in Patients With Immunoglobulin A Nephropathy (IgAN)
This is a Phase II, open-label study designed to To evaluate the safety and efficacy of NM8074 in reducing proteinuria relative to baseline in IgAN patients after 99 days of treatment.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Evaluate the Effect of ARGX-121 on the Change in Proteinuria in Adult Participants With IgAN#911473
- Albuminuria Reduction With Renin Angiotensin System Inhibitors in SCA Patients#845417
- Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus#1349796
- Renal Survival in Patients with Lupus Nephritis#887318
- Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)#1228547
Record · ID 1198150
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive